Tumor cell-specific AIM2 regulates growth and invasion of cutaneous squamous cell carcinoma
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
// Mehdi Farshchian 1, 2 , Liisa Nissinen 1, 2 , Elina Siljamäki 1, 2 , Pilvi Riihilä 1, 2 , Minna Piipponen 1, 2 , Atte Kivisaari 1, 2 , Markku Kallajoki 3 , Reidar Grénman 4 , Juha Peltonen 5 , Sirkku Peltonen 1 , Koen D. Quint 6, 7 , Jan Nico Bouwes Bavinck 6 and Veli-Matti Kähäri 1, 2 1 Department of Dermatology, University of Turku and Turku University Hospital, Turku, Finland 2 MediCity Research Laboratory, University of Turku, Turku, Finland 3 Department of Pathology, University of Turku and Turku University Hospital, Turku, Finland 4 Department of Otorhinolaryngology - Head and Neck Surgery, University of Turku and Turku University Hospital, Turku, Finland 5 Department of Cell Biology and Anatomy, University of Turku, Turku, Finland 6 Department of Dermatology, Leiden University Medical Center, Leiden, The Netherlands 7 DDL Diagnostic Laboratory, Rijswijk, The Netherlands Correspondence to: Veli-Matti Kähäri, email: veli-matti.kahari@utu.fi Keywords: skin, cancer, inflammasome, AIM2, keratinocyte Received: June 29, 2016 Accepted: April 18, 2017 Published: May 02, 2017 ABSTRACT Cutaneous squamous cell carcinoma (cSCC) is the most common metastatic skin cancer. Inflammation is a typical feature in cSCC progression. Analysis of the expression of inflammasome components in cSCC cell lines and normal human epidermal keratinocytes revealed upregulation of the expression of AIM2 mRNA and protein in cSCC cells. Elevated levels of AIM2 mRNA were noted in cSCCs in vivo compared with normal skin. Strong and moderate tumor cell specific expression of AIM2 was detected with immunohistochemistry (IHC) in sporadic human cSCCs in vivo , whereas expression of AIM2 was moderate in cSCC in situ (cSCCIS) and low or absent in actinic keratosis (AK) and normal skin. IHC of cSCCs, cSCCIS and AKs from organ transplant recipients also revealed strong and moderate tumor cell specific expression of AIM2 in cSCCs. Knockdown of AIM2 resulted in reduction in viability of cSCC cells and onset of apoptosis. RNA-seq and pathway analysis after knockdown of AIM2 in cSCC cells revealed downregulation of the biofunction category Cell cycle and upregulation of the biofunction category Cell Death and Survival . Knockdown of AIM2 also resulted in reduction in invasion of cSCC cells and downregulation in production of invasion proteinases MMP1 and MMP13. Knockdown of AIM2 resulted in suppression of growth and vascularization of cSCC xenografts in vivo . These results provide evidence for the role of AIM2 in the progression of cSCC and identify AIM2 inflammasome function as a potential therapeutic target in these invasive and metastatic tumors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inflammasomes in health and disease
Strowig, T., Henao-Mejia, J., Elinav, E., & Flavell, R. (2012) · Nature · doi:10.1038/nature10759 · Cited by 2,230 · cited 1×
“Inflammasomes serve as sensors for exogenous and endogenous danger signals and trigger activation and secretion of interleukin (IL)-1β and IL-18 [11].”
BackgroundSkin cancers after organ transplantation
Euvrard, S., Kanitakis, J., & Claudy, A. (2003) · New England Journal of Medicine · doi:10.1056/nejmra022137 · Cited by 1,575
The AIM2 inflammasome is essential for host defense against cytosolic bacteria and DNA viruses
Rathinam, V. A. K., Jiang, Z., Waggoner, S. N., Sharma, S., Cole, L. E., Waggoner, L., Vanaja, S. K., Monks, B. G., Ganesan, S., Latz, E., et al. (2010) · Nature Immunology · doi:10.1038/ni.1864 · Cited by 1,331
Inflammation and cancer: how hot is the link?
Aggarwal, B. B., Shishodia, S., Sandur, S. K., Pandey, M. K., & Sethi, G. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.06.029 · Cited by 1,312
Nissinen, L., Farshchian, M., Riihilä, P., & Kähäri, V.-M. (2016) · Cell and Tissue Research · doi:10.1007/s00441-016-2457-z · Cited by 80 · cited 1×
“com/oncotarget the microenvironment of the premalignant skin lesion, such as alteration of the composition of the epidermal basement membrane and dermal extracellular matrix, and accumulation of inflammatory cells and microbial structures, are possible mechanisms for the role of inflammation in progression of AK to cS…”
BackgroundSelf-citation
Cited by
Inflammatory memory sensitizes skin epithelial stem cells to tissue damage
Naik, S., Larsen, S. B., Gomez, N. C., Alaverdyan, K., Sendoel, A., Yuan, S., Polak, L., Kulukian, A., Chai, S., & Fuchs, E. (2017) · Nature · doi:10.1038/nature24271 · Cited by 745
Diverging inflammasome signals in tumorigenesis and potential targeting
Karki, R., & Kanneganti, T.-D. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-019-0123-y · Cited by 641
The AIM 2 inflammasome: Sensor of pathogens and cellular perturbations
Lugrin, J., & Martinon, F. (2018) · Immunological Reviews · doi:10.1111/imr.12618 · Cited by 333
Role of AIM2 inflammasome in inflammatory diseases, cancer and infection
Sharma, B. R., Karki, R., & Kanneganti, T. (2019) · European Journal of Immunology · doi:10.1002/eji.201848070 · Cited by 294
Hsu, P.-C., Chao, T.-K., Chou, Y.-C., Yu, M.-H., Wang, Y.-C., Lin, Y.-H., Lee, Y.-L., Liu, L.-C., & Chang, C.-C. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10194529 · Cited by 20
“On the other hand, knockdown of AIM2 inflammasome resulted in the suppression of growth and vascularization of cutaneous squamous cell carcinoma xenografts in vivo [18].”
Background
Metadata
- Authors
- Farshchian, M., Nissinen, L., Siljamäki, E., Riihilä, P., Piipponen, M., Kivisaari, A., Kallajoki, M., Grénman, R., Peltonen, J., Peltonen, S., Quint, K. D., Bavinck, J. N. B., & Kähäri, V.-M.
- Venue
- Oncotarget
- Publisher
- Impact Journals, LLC
- Published
- 2017-05-02
- Volume
- 8
- Issue
- 28
- Pages
- 45825-45836
- ISSN
- 1949-2553 (ISSN-L)
- OpenAlex
- W2610806592
- Cited by
- 80
- References
- 5
- FWCI
- 3.34
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Tumor cell-specific AIM2 regulates growth and invasion of cutaneous squamous cell carcinoma. https://app.cochat.ai/papers/10.18632/oncotarget.17573
- The paper
- Farshchian, M., Nissinen, L., Siljamäki, E., Riihilä, P., Piipponen, M., Kivisaari, A., Kallajoki, M., Grénman, R., Peltonen, J., Peltonen, S., Quint, K. D., Bavinck, J. N. B., & Kähäri, V.-M. (2017). Tumor cell-specific AIM2 regulates growth and invasion of cutaneous squamous cell carcinoma. Oncotarget. https://doi.org/10.18632/oncotarget.17573
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.